DMC Biotechnologies' Grant

DMC Biotechnologies raised a round of funding on November 10, 2017. Investors include National Science Foundation.

DMC Biotechnologies develops and commercializes bio-based products for multiple product markets, including pharmaceuticals, specialty chemicals, flavors, fragrances, nutraceuticals, and APIs.…

Articles about DMC Biotechnologies' Grant: